Cargando…
Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771905/ https://www.ncbi.nlm.nih.gov/pubmed/33385796 http://dx.doi.org/10.1016/j.thromres.2020.12.013 |
| _version_ | 1783629765573345280 |
|---|---|
| author | Kollias, Anastasios Kyriakoulis, Konstantinos G. Syrigos, Nikolaos K. Stergiou, George S. |
| author_facet | Kollias, Anastasios Kyriakoulis, Konstantinos G. Syrigos, Nikolaos K. Stergiou, George S. |
| author_sort | Kollias, Anastasios |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7771905 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77719052020-12-30 Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit? Kollias, Anastasios Kyriakoulis, Konstantinos G. Syrigos, Nikolaos K. Stergiou, George S. Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2021-03 2020-12-29 /pmc/articles/PMC7771905/ /pubmed/33385796 http://dx.doi.org/10.1016/j.thromres.2020.12.013 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editors-in-Chief Kollias, Anastasios Kyriakoulis, Konstantinos G. Syrigos, Nikolaos K. Stergiou, George S. Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit? |
| title | Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit? |
| title_full | Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit? |
| title_fullStr | Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit? |
| title_full_unstemmed | Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit? |
| title_short | Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit? |
| title_sort | anticoagulation therapy in covid-19: is there a dose-dependent benefit? |
| topic | Letter to the Editors-in-Chief |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771905/ https://www.ncbi.nlm.nih.gov/pubmed/33385796 http://dx.doi.org/10.1016/j.thromres.2020.12.013 |
| work_keys_str_mv | AT kolliasanastasios anticoagulationtherapyincovid19isthereadosedependentbenefit AT kyriakouliskonstantinosg anticoagulationtherapyincovid19isthereadosedependentbenefit AT syrigosnikolaosk anticoagulationtherapyincovid19isthereadosedependentbenefit AT stergiougeorges anticoagulationtherapyincovid19isthereadosedependentbenefit |